Sign up to save your podcasts
Or
Share #46 Gil Bashe's Top 10 Health Issues to Follow
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
#46 Gil Bashe's Top 10 Health Issues to Follow
Gil Bashe's Top 10 Health Issues to Follow
Gil's Article in Medika life: Top 10 Issues
Please find Gil Bashe's corresponding article: The Top 10 Public Health Policy Issues for Election Year 2024 Everyone is Thinking How Cost Will Impact Innovation and Access to Care with today’s live discussion.
Michael Mann, MHA asks Gil on Planetary Health First Mars Next what health industry conferences are on my radar screen for 2024 - here are eight that
More about Gil Bashe:
More about Gil on LinkedIn
Voice for innovation and people's and the planet's health with @finnpartners | @medikalife | @HCNowRadio | @GalienFdn. Championing #biopharma #climatetech #digitalhealth #ecohealth #healthinnovation
Champion for innovation to sustain people's and the planet's health, his energy and efforts center around making it possible for bold ideas to navigate often fragmented sectors and systems.
Gil has been tapped by PharmaVOICE "as one of the 100 most inspiring people in healthcare," included in the Fast Company “50 People to Watch in the New World of Work,”; chosen as an MM&M as a "Top 10 Innovation Catalyst;" by PRWeek/MM&M as a "Top 50 Health Influencer;" noted by digital-health news and opinion platform Medika Life as a "Top 50 Healthcare Influencer;" recognized by the PRSA Health Academy for "Excellence in Public Relations;" by PM360 with its "Trailblazer Lifetime Achievement Award" and selected for the PR News "Hall of Fame," PRWeek "Top 30 Health Influencers and PRovoke Media "Top 25 Innovators."
As a leader of four top agencies cited by PRovoke Media (The Holmes Report/Inside PR) as "Healthcare PR Agency of the Year" winners, Gil encourages purpose-based culture to elevate client performance. As
a voice for change, he is a Medika Life and "Being Well" editor and a Top 10 digital/health influencer. Gil serves on several national industry and patient advocacy boards.
Gil has led agency teams contributing to numerous global med/tech and biopharma billion-dollar blockbusters in cancer, diabetes, heart, respiratory, women's health and non-communicable and orphan disease therapies. His background in payer, provider, policy, pharma marketing and patient-advocacy communications enables him to integrate ideas that impact patient access to health innovation.
Dedicated to inspiring colleagues to collaborate and marshal their talents for the common good, he was Group Company CEO, CommonHealth, and at WPP Group sister-company Hill + Knowlton, its first Global Practice Head. He served as CEO of Health!Quest Global Communication Partners is a GTCR-backed private equity firm with $10 billion in active assets.
Before FINN Partners, Gil held leadership positions with New York-based agencies Makovsky, Medicus (today part of Publicis Healthcare), and pioneering integrated health-marketing agency Sutton Healthcare Group (acquired by Medicus). As a drug development policy and environment affairs lobbyist, he served as a director with the New Jersey Health Products Council, representing the research-based health products industry. He completed his military service as a paratrooper and combat medic with the rank of staff sergeant.
Gil Bashe is planning to attend in the States during the year:
ViVE, HIMSS, HITLAB, HLTH, Decentralized Trials & Research Alliance (DTRA), The Galien Foundation, Digital Health & AI Innovation Summit (DHAI) and absolutely CNS Summit.
View all episodes
Gil Bashe's Top 10 Health Issues to Follow
Gil's Article in Medika life: Top 10 Issues
Please find Gil Bashe's corresponding article: The Top 10 Public Health Policy Issues for Election Year 2024 Everyone is Thinking How Cost Will Impact Innovation and Access to Care with today’s live discussion.
Michael Mann, MHA asks Gil on Planetary Health First Mars Next what health industry conferences are on my radar screen for 2024 - here are eight that
More about Gil Bashe:
More about Gil on LinkedIn
Voice for innovation and people's and the planet's health with @finnpartners | @medikalife | @HCNowRadio | @GalienFdn. Championing #biopharma #climatetech #digitalhealth #ecohealth #healthinnovation
Champion for innovation to sustain people's and the planet's health, his energy and efforts center around making it possible for bold ideas to navigate often fragmented sectors and systems.
Gil has been tapped by PharmaVOICE "as one of the 100 most inspiring people in healthcare," included in the Fast Company “50 People to Watch in the New World of Work,”; chosen as an MM&M as a "Top 10 Innovation Catalyst;" by PRWeek/MM&M as a "Top 50 Health Influencer;" noted by digital-health news and opinion platform Medika Life as a "Top 50 Healthcare Influencer;" recognized by the PRSA Health Academy for "Excellence in Public Relations;" by PM360 with its "Trailblazer Lifetime Achievement Award" and selected for the PR News "Hall of Fame," PRWeek "Top 30 Health Influencers and PRovoke Media "Top 25 Innovators."
As a leader of four top agencies cited by PRovoke Media (The Holmes Report/Inside PR) as "Healthcare PR Agency of the Year" winners, Gil encourages purpose-based culture to elevate client performance. As
a voice for change, he is a Medika Life and "Being Well" editor and a Top 10 digital/health influencer. Gil serves on several national industry and patient advocacy boards.
Gil has led agency teams contributing to numerous global med/tech and biopharma billion-dollar blockbusters in cancer, diabetes, heart, respiratory, women's health and non-communicable and orphan disease therapies. His background in payer, provider, policy, pharma marketing and patient-advocacy communications enables him to integrate ideas that impact patient access to health innovation.
Dedicated to inspiring colleagues to collaborate and marshal their talents for the common good, he was Group Company CEO, CommonHealth, and at WPP Group sister-company Hill + Knowlton, its first Global Practice Head. He served as CEO of Health!Quest Global Communication Partners is a GTCR-backed private equity firm with $10 billion in active assets.
Before FINN Partners, Gil held leadership positions with New York-based agencies Makovsky, Medicus (today part of Publicis Healthcare), and pioneering integrated health-marketing agency Sutton Healthcare Group (acquired by Medicus). As a drug development policy and environment affairs lobbyist, he served as a director with the New Jersey Health Products Council, representing the research-based health products industry. He completed his military service as a paratrooper and combat medic with the rank of staff sergeant.
Gil Bashe is planning to attend in the States during the year:
ViVE, HIMSS, HITLAB, HLTH, Decentralized Trials & Research Alliance (DTRA), The Galien Foundation, Digital Health & AI Innovation Summit (DHAI) and absolutely CNS Summit.